rs3732183

plus

Geno	Mag	Summary
(G;G)	0	common in clinvar

Make rs3732183(A;A)

Make rs3732183(A;G)

Reference

GRCh38 38.1/141

Chromosome

2

Position

47466820

Gene

MSH2

is a	snp
is	mentioned by
dbSNP	rs3732183
dbSNP (classic)	rs3732183
ClinGen	rs3732183
ebi	rs3732183
HLI	rs3732183
Exac	rs3732183
Gnomad	rs3732183
Varsome	rs3732183
LitVar	rs3732183
Map	rs3732183
PheGenI	rs3732183
Biobank	rs3732183
1000 genomes	rs3732183
hgdp	rs3732183
ensembl	rs3732183
geneview	rs3732183
scholar	rs3732183
google	rs3732183
pharmgkb	rs3732183
gwascentral	rs3732183
openSNP	rs3732183
23andMe	rs3732183
SNPshot	rs3732183
SNPdbe	rs3732183
MSV3d	rs3732183
GWAS Ctlg	rs3732183

GMAF

0.4669

Max Magnitude

0

?

(A;A) (A;G) (G;G)

28

[PMID 20091185] MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy

ClinVar
Risk	rs3732183(A;A)
Alt	rs3732183(A;A)
Reference	Rs3732183(G;G)
Significance	Non-pathogenic
Disease	Lynch syndrome not specified Hereditary cancer-predisposing syndrome Lynch syndrome I
Variation	info
Gene	MSH2
CLNDBN	Lynch syndrome not specified Hereditary cancer-predisposing syndrome Lynch syndrome I
Reversed	0
HGVS	NC_000002.11:g.47693959G>A
CLNSRC	International Society for Gastrointestinal Hereditary Tumours
CLNACC	RCV000030241.4, RCV000035358.9, RCV000132147.1, RCV000144614.1,

[PMID 19930554 ] Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

[PMID 31035658 ] Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.